![Chang Ho Ahn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chang Ho Ahn
Directeur/Membre du Conseil chez TheraTarget, Inc.
Postes actifs de Chang Ho Ahn
Sociétés | Poste | Début | Fin |
---|---|---|---|
TheraTarget, Inc.
![]() TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology TheraTarget, Inc. develops innovative polymer therapeutics for the treatment of cancer. It is a biopharmaceutical drug delivery company developing a variety of polymer-drug conjugates utilizing our nanopolymer drug delivery technologies. The company was founded in October 2008 and is headquartered in Salt Lake, UT. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Chang Ho Ahn
Anciens postes connus de Chang Ho Ahn
Sociétés | Poste | Début | Fin |
---|---|---|---|
REXAHN PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 22/06/2015 | 31/08/2017 |
Président | 01/05/2005 | 22/06/2015 | |
Directeur Technique/Scientifique/R&D | 08/03/2011 | - | |
Fondateur | 19/03/2001 | 31/08/2017 | |
President | 01/05/2005 | 05/02/2013 | |
Rexahn Corp. | Directeur Général | 01/03/2001 | 01/05/2005 |
Président | 01/03/2001 | 01/05/2005 | |
The Society of Biomedical Research | President | 01/01/2000 | 01/01/2003 |
Center for Drug Evaluation & Research | Corporate Officer/Principal | 01/01/1988 | 01/01/2001 |
Formation de Chang Ho Ahn
The Ohio State University | Doctorate Degree |
Creighton University | Undergraduate Degree |
Seoul National University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Corée du Sud | 2 |
Opérationnelle
Director/Board Member | 2 |
Chairman | 2 |
President | 2 |
Sectorielle
Consumer Services | 4 |
Health Technology | 3 |
Government | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 5 |
---|---|
Rexahn Pharmaceuticals, Inc.
![]() Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
The Society of Biomedical Research | |
Center for Drug Evaluation & Research | Government |
Rexahn Corp. | Finance |
TheraTarget, Inc.
![]() TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology TheraTarget, Inc. develops innovative polymer therapeutics for the treatment of cancer. It is a biopharmaceutical drug delivery company developing a variety of polymer-drug conjugates utilizing our nanopolymer drug delivery technologies. The company was founded in October 2008 and is headquartered in Salt Lake, UT. | Health Technology |
- Bourse
- Insiders
- Chang Ho Ahn
- Expérience